Targeting key cellular proteins may provide new opportunities to diagnose, prevent, and treat pulmonary arterial hypertension ...
AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, plus infant COVID-19 ...
IDSA recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines immunocompromised patients.
GE HealthCare issued updated use instructions for certain patient monitoring devices, according to an FDA alert.
Updated formulas from Pfizer, Moderna, and Novavax target the circulating XFG variant for older adults and high-risk ...
Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
The ERS is urging European countries to adopt "tobacco endgame" policies to permanently reduce tobacco use and end the ...
A clinical trial will evaluate a weekly dry powder nasal spray's ability to boost natural defenses and prevent asthma infections.
UCLA Health combines biopsy, staging, and surgery into a single session to reduce delays and improve lung cancer patient ...
The American Lung Association provides personalized guidance from RTs and nurses to help pulmonary fibrosis patients manage ...
CVS and Walgreens are expanding walk-in access, multi-vaccine scheduling, and respiratory illness testing ahead of peak viral activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results